Report
Michael B. Schäfer

Wacker Chemie AG : More cautious on Biosolutions? Poly-Si strategy and solar-grade performance remain in spotlight as demand weakened recently

>Upcoming CMD may largely confirm ambitious 2030 targets - Wacker Chemie is hosting its CMD on the 19 September at its largest single site in Burghausen. We don’t expect a full overhaul of strategic cornerstones laid out until 2030 back in 2022. The group sales target of more than € 10bn and >20% EBITDA margin (>€ 2bn EBITDA) target looked ambitious in 2022 and remain ambitious in light of € 6.1bn sales and € 1.2bn EBITDA (18.2%) generated on average in 2019-2023. The...
Underlying
Wacker Chemie AG

Wacker Chemie is active in chemical products. Co. operates in five divisions: Wacker Silicones, which provides products ranging from silicone fluids and emulsions, resins, elastomers and sealants, to silanes and pyrogenic silica grades; Wacker Polymers, which manufactures binders and polymeric additives (such as dispersible polymer powders and dispersions); Wacker Biosolutions, which supplies customized biotech and catalog products for the fine-chemical sector; Wacker Polysilicon, which produces hyperpure polysilicon for the semiconductor, electronics and above all, solar sectors; and Siltronic, which supplies semiconductor manufacturers with silicon wafers.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Michael B. Schäfer

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch